摘要 |
Compounds of formula (I) and salts and solvates are provided: In a first aspect therefore, the invention provides a compound of formula (I) or a salt or solvate thereof: wherein R<SUP>5</SUP> is selected from halogen, C<SUB>1-6</SUB>alkyl, C<SUB>1-6</SUB>alkyl substituted with one or more fluorine atoms, C<SUB>1-6</SUB> alkoxy, C<SUB>1-6</SUB> alkoxy substituted with one or more fluorine atoms, and cyano; R<SUP>6</SUP> is selected from halogen, C<SUB>1-6</SUB>alkyl, C<SUB>1-6</SUB>alkyl substituted with one or more fluorine atoms, C<SUB>3-6</SUB>cycloalkyl, C<SUB>3</SUB>-<SUB>6</SUB>cycloalkyl substituted with one or more fluorine atoms, C<SUB>1-6</SUB> alkoxy, C<SUB>1-6</SUB> alkoxy substituted with one or more fluorine atoms, and cyano; and Q is hydrogen or C <SUB>1-6</SUB> alkyl. The compounds are M<SUB>1</SUB> agonists and are useful for therapy, for example in the treatment of psychotic disorders and cognitive impairment. |
申请人 |
GLAXO GROUP LIMITED;BUDZIK, BRIAN;COOPER, DAVID, GWYN;FORBES, IAN, THOMSON;GARZYA, VINCENZO;JIN, JIAN;SHI, DONGCHUAN;SMITH, PAUL, WILLIAM;WALKER, GRAHAM |
发明人 |
BUDZIK, BRIAN;COOPER, DAVID, GWYN;FORBES, IAN, THOMSON;GARZYA, VINCENZO;JIN, JIAN;SHI, DONGCHUAN;SMITH, PAUL, WILLIAM;WALKER, GRAHAM |